(Q38118663)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818224%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

3 references

25 January 2021

8 February 2021

8 April 2021

Tubulin-interactive stilbene derivatives as anticancer agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818224%20AND%20SRC:MED&resulttype=core&format=json

phytogenic antineoplastic agents

4 March 2020

main subject

1 reference

25 January 2021

1 reference

8 February 2021

1 reference

8 April 2021

Jakub Różański

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818224%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

1 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818224%20AND%20SRC:MED&resulttype=core&format=json

Cellular & Molecular Biology Letters

4 March 2020

1 September 2013

3 references

25 January 2021

8 February 2021

8 April 2021

4 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818224%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

25 January 2021

8 February 2021

8 April 2021

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818224%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818224%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

368-397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818224%20AND%20SRC:MED&resulttype=core&format=json

Targeted treatment of choroidal neovascularization using integrin-mediated sterically stabilized liposomes loaded with combretastatin A4.

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Effect of the second-generation vascular disrupting agent OXi4503 on tumor vascularity

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Microtubules as a target for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Synthesis and cytotoxic activities of 4,5-diarylisoxazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Microtubule polymerization dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Curcumin recognizes a unique binding site of tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Convergent synthesis and biological evaluation of 2-amino-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as microtubule targeting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Oxidative metabolism of combretastatin A-1 produces quinone intermediates with the potential to bind to nucleophiles and to enhance oxidative stress via free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Inhibition of proliferative retinopathy by the anti-vascular agent combretastatin-A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles That Are Cytotoxic against Combretastatin A Resistant Tumor Cells and Vascular Disrupting in a Cisplatin Resistant Germ Cell Tumor Model

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Structure of the alpha beta tubulin dimer by electron crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Synthesis and cytotoxic evaluation of combretafurazans

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Tubulin-interactive natural products as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

The biology of the combretastatins as tumour vascular targeting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Asymmetric synthesis of antimitotic combretadioxolane with potent antitumor activity against multi-drug resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, is a potent inducer of apoptosis in colon cancer cells via targeting microtubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Combretastatin family member OXI4503 induces tumor vascular collapse through the induction of endothelial apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

AVE8062: a new combretastatin derivative vascular disrupting agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Microtubule assembly dynamics: an attractive target for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Identification of novel antitubulin agents by using a virtual screening approach based on a 7-point pharmacophore model of the tubulin colchi-site

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Structure of tubulin at 6.5 A and location of the taxol-binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Modeling the yew tree tubulin and a comparison of its interaction with paclitaxel to human tubulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Resveratrol and resveratrol analogues--structure-activity relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Synthesis and biological evaluation of 2-substituted-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Spindle mechanics and dynamics during mitosis in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Microtubule targeting agents: from biophysics to proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Oxazole-bridged combretastatin A analogues with improved anticancer properties

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

1,2,3-triazole analogs of combretastatin A-4 as potential microtubule-binding agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Oscillatory movements of monooriented chromosomes and their position relative to the spindle pole result from the ejection properties of the aster and half-spindle

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Leukemia regression by vascular disruption and antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Quantitative analysis of the effect of tubulin isotype expression on sensitivity of cancer cell lines to a set of novel colchicine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Effects of tetramethoxystilbene on hormone-resistant breast cancer cells: biological and biochemical mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4).

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

E-Combretastatin and E-resveratrol structural modifications: antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Vascular disrupting activity of tubulin-binding 1,5-diaryl-1H-imidazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Structural basis for the regulation of tubulin by vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Comparative molecular field analysis study of stilbene derivatives active against A549 lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Tracking the ends: a dynamic protein network controls the fate of microtubule tips

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Potent, orally active heterocycle-based combretastatin A-4 analogues: synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Combretastatin a-4 analogs as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Antitumor effects due to irreversible stoppage of tumor tissue blood flow: evaluation of a novel combretastatin A-4 derivative, AC7700.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Vascular targeting agents as cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Natural products to drugs: natural product-derived compounds in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Antineoplastic agents. 548. Synthesis of iodo- and diiodocombstatin phosphate prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Pharmaceutical design of antimitotic agents based on combretastatins.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Support of a free radical mechanism for enhanced antitumor efficacy of the microtubule disruptor OXi4503.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Novel B-ring modified combretastatin analogues: syntheses and antineoplastic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Stabilization of microtubule dynamics at anaphase onset promotes chromosome segregation

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Design of combretastatin A-4 analogs as tubulin targeted vascular disrupting agent with special emphasis on their cis-restricted isomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Antitumor and antivascular effects of AVE8062 in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Mitotic spindle assembly and chromosome segregation: refocusing on microtubule dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Nucleotide-dependent bending flexibility of tubulin regulates microtubule assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Medicinal chemistry of combretastatin A4: present and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Microtubule assembly nucleated by isolated centrosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2478%2FS11658-013-0094-Z

Resveratrol derivative, trans-3,5,4'-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation.

21 January 2018

1 reference

12 December 2020

Antitumor agents. 181. Synthesis and biological evaluation of 6,7,2',3',4'-substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a new class of antimitotic antitumor agents

1 reference

12 December 2020

The tubulin colchicine domain: a molecular modeling perspective

1 reference

12 December 2020

Small molecule vascular disrupting agents: potential new drugs for cancer treatment

1 reference

12 December 2020

Differentiation and definition of vascular-targeted therapies.

1 reference

12 December 2020

A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P)

1 reference

12 December 2020

Synthesis and biological properties of bioreductively targeted nitrothienyl prodrugs of combretastatin A-4

1 reference

12 December 2020

The vascular disrupting agent ombrabulin (AVE8062) enhances the efficacy of standard therapies in head and neck squamous cell carcinoma xenograft models.

1 reference

12 December 2020

Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes

1 reference

12 December 2020

Syntheses and antitumor activity of cis-restricted combretastatins: 5-membered heterocyclic analogues

1 reference

12 December 2020

Synthesis and evaluation of analogs of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents

1 reference

12 December 2020

Stable combretastatin A-4 analogues with sub-nanomolar efficacy against chemoresistant HT-29 cells

1 reference

12 December 2020

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature

1 reference

12 December 2020

Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4',5-trimethoxylstilbene-3'-O-phosphate disodium (M410).

1 reference

12 December 2020

Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization

1 reference

12 December 2020

DAT-230, a novel microtubule inhibitor, exhibits potent anti-tumor activity by inducing G2/M phase arrest, apoptosis in vitro and perfusion decrease in vivo to HT-1080.

1 reference

12 December 2020

Isolation and structure of combretastatin

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1139/V82-202

Identifiers

DOI

10.2478/S11658-013-0094-Z

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818224%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818224%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

PubMed publication ID

23818224

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23818224%20AND%20SRC:MED&resulttype=core&format=json